Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2017-2021
- SKU ID : TNV-IRTNTR11320 10430875
- |
- Publishing Date: 29-Dec-2016
- |
- Region: Global
- |
- No. of pages: 77
About CINV Drugs
The launch of extended half-life drugs in the market is expected to substantially improve the adoption rates, owing to their ability to act for prolonged periods of time. For instance, Heron Therapeutics' SUSTOL and Tesaro's VARUBI offer protection against CINV for five days and seven days, respectively. Additionally, the emergence of oral therapies is expected to enhance the patient compliance, resulting in market growth.
Technavio’s analysts forecast the global CINV drugs market to grow at a CAGR of 5.41% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global CINV drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of CINV drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GlaxoSmithKline
• Helsinn
• Heron Therapeutics
• Merck
• Tesaro
Other prominent vendors
• Acacia Pharma
• Aphios
• Baxter Healthcare
• Dr. Reddy's Laboratories
• Eisai
• Especificos Stendhal
• F. Hoffmann-La Roche
• Kyowa Hakko Kirin
• Lee’s Pharmaceutical Holdings
• Midatech Pharma
• Mundipharma
• Mylan
• Ono Pharmaceutical
• OPKO Health
• Orchid Chemicals & Pharmaceuticals
• Otsuka Pharmaceutical
• Purdue Pharma
• Sandoz (a subsidiary of Novartis)
• SciClone Pharmaceuticals
• Shin Nippon Biomedical Laboratories
• Solasia Pharma K.K.
• Specialised Therapeutics
• Sun Pharma
• Taiho Pharmaceutical
• Teva Pharmaceuticals
Market driver
• Growing preference of chemotherapy drugs in developing countries
• For a full, detailed list, view our report
Market challenge
• Growing popularity of alternate therapies for the treatment of cancer in developed countries
• For a full, detailed list, view our report
Market trend
• Increasing inorganic growth strategies likely to fuel the market growth
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The launch of extended half-life drugs in the market is expected to substantially improve the adoption rates, owing to their ability to act for prolonged periods of time. For instance, Heron Therapeutics' SUSTOL and Tesaro's VARUBI offer protection against CINV for five days and seven days, respectively. Additionally, the emergence of oral therapies is expected to enhance the patient compliance, resulting in market growth.
Technavio’s analysts forecast the global CINV drugs market to grow at a CAGR of 5.41% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global CINV drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of CINV drugs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GlaxoSmithKline
• Helsinn
• Heron Therapeutics
• Merck
• Tesaro
Other prominent vendors
• Acacia Pharma
• Aphios
• Baxter Healthcare
• Dr. Reddy's Laboratories
• Eisai
• Especificos Stendhal
• F. Hoffmann-La Roche
• Kyowa Hakko Kirin
• Lee’s Pharmaceutical Holdings
• Midatech Pharma
• Mundipharma
• Mylan
• Ono Pharmaceutical
• OPKO Health
• Orchid Chemicals & Pharmaceuticals
• Otsuka Pharmaceutical
• Purdue Pharma
• Sandoz (a subsidiary of Novartis)
• SciClone Pharmaceuticals
• Shin Nippon Biomedical Laboratories
• Solasia Pharma K.K.
• Specialised Therapeutics
• Sun Pharma
• Taiho Pharmaceutical
• Teva Pharmaceuticals
Market driver
• Growing preference of chemotherapy drugs in developing countries
• For a full, detailed list, view our report
Market challenge
• Growing popularity of alternate therapies for the treatment of cancer in developed countries
• For a full, detailed list, view our report
Market trend
• Increasing inorganic growth strategies likely to fuel the market growth
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
